Liver Failure Clinical Trials

A listing of Liver Failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 209 clinical trials
Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure

HBV-related liver failure (HBV-LF), a dramatic clinical syndrome, is characterized with massive necrosis of liver cells. Liver transplantation might be the most effective therapy for HBV-LF

hepatitis b surface antigen
clinical syndrome
liver transplant
meld score
  • 08 Nov, 2020
  • 1 location
Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure

The purpose of this study is to determine whether recombinant human hepatocyte growth factor is safe and effective in the treatment of fulminant and late-onset hepatic failure.

hepatic failure
hepatocyte growth factor
liver transplant
  • 07 Nov, 2020
  • 1 location
Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF)

This is an interventional, double blind, randomized (2:1), and placebo-controlled study of 1 dose regimen of HepaStem in patients recently diagnosed (1 week) with ACLF grade 1 or 2 on top of Standard of Care (SoC), and for whom the diagnosis is not resolved on the day of infusion.

dose regimen
  • 26 Jan, 2021
  • 8 locations
Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis

detoxification in acute liver failure by removal of protein bound as well as water soluble substances.

  • 07 Nov, 2020
  • 1 location
Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates

Intestinal failure associated liver disease is a cholestatic liver disease associated with prolonged need for parenteral nutrition that can lead to such significant complications as liver

  • 24 Jan, 2021
  • 1 location
The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy

will be applied 24-48 hours after extensive hepatectomy. In order to evaluate the security and effectiveness of the device, liver function, liver volume, the incidence of liver failure and other

  • 24 Sep, 2021
  • 1 location
Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity

Hepatitis B virus (HBV) leads to life-threatening disease like liver failure and liver cancer. For most, a cure is unattainable as current HBV antiviral therapy (using nucleoside analogues) are

nucleoside analog
hepatitis b antigen
antiviral therapy
  • 23 Sep, 2021
  • 2 locations
Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors

of unresectable hepatobiliary cancer, continue to die of liver failure from progressive disease in the liver. Percutaneous ethanol injections, chemoembolization, cryotherapy and thermal

stereotactic body radiation therapy
liver disease
liver metastasis
  • 07 Nov, 2020
  • 1 location
Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label Study (SAFADIE)

hepatitis, as well as hepatic failure resulting in transplantation or death, have been reported with administration of disulfiram (PDR 2005). The incidence of liver disease among alcoholics is

drugs of abuse
alcohol abuse
  • 07 Nov, 2020
  • 1 location
Induction of Transplant Tolerance in LDLT Via iTS

The purpose of this clinical trial is to examine the immunotolerance-inducing ability (effectiveness) of induced inhibitory T cells JB-101 in patients with living-donor liver transplantation using "whether or not operational tolerance is achieved" as an index. And the safety of JB-101 will be evaluated.

  • 24 Sep, 2021
  • 3 locations